The Empty Capsules Market is Set to Experience Steady Growth at an 11% CAGR Through 2030

The Business Research Company’s The Empty Capsules Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, October 12, 2026 /EINPresswire.com/ — The empty capsules market is becoming an important segment within the broader pharmaceutical landscape, driven by evolving consumer needs and technological advances. As demand for precise and versatile dosage forms grows, this market is set to see significant expansion. Below, we explore its current size, key drivers, market leaders, and emerging opportunities shaping its future.

Empty Capsules Market Size and Its Position in Pharmaceuticals
The empty capsules market is expected to surpass $6 billion by 2030. When compared to the overall Pharmaceuticals industry, which is forecast to reach $2,496 billion by the same year, empty capsules will represent approximately 0.2% of the total market value, highlighting their niche yet vital role in drug delivery.

Request A Free Sample Of The Empty Capsules Market Report
https://thebusinessresearchcompany.com/sample_request?id=77500206&type=smp&name=Empty%20Capsules%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Main Drivers Behind the Empty Capsules Market Growth
The surge in the empty capsules market is fueled by the increasing demand for pharmaceutical and nutraceutical products. As chronic diseases rise and preventive care gains focus, more consumers are using prescription drugs, over-the-counter medicines, and supplements that require capsules for benefits like precise dosing and enhanced patient compliance.

Another important growth factor is the rising preference for vegetarian and non-gelatin capsules. Consumers are gravitating toward plant-based, vegan, halal, kosher, and clean-label options, encouraging manufacturers to switch from traditional gelatin to alternatives such as HPMC and pullulan. These materials also provide improved stability for moisture-sensitive ingredients, broadening their application.

Access The Detailed Empty Capsules Market Report Here
https://thebusinessresearchcompany.com/report/empty-capsules-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Innovations in Capsule Manufacturing and Drug Delivery Technologies
Advancements in capsule technology, including delayed-release, sustained-release, enteric-coated, and liquid-filled capsules, enable more efficient drug formulations with better bioavailability and patient adherence. Concurrently, manufacturing processes have improved in precision and scale, supporting next-generation therapies and greater production flexibility.

Primary Capsule Types in the Market
The market divides mainly into gelatin and non-gelatin capsules. Gelatin capsules are projected to remain the dominant segment by 2030, making up 71% of the market—about $4 billion. Their low cost, compatibility with a wide range of active ingredients, ease of swallowing, and improved filling technologies contribute to their sustained popularity.

Additional Market Segmentation by Functionality, Application, and End-User
The empty capsules market is further categorized by functionality into immediate-release, sustained-release, and delayed-release capsules. Regarding applications, it serves antibiotic and antibacterial drugs, dietary supplements, antacid and antiflatulent preparations, antianemic drugs, anti-inflammatory medications, cardiovascular therapies, cough and cold remedies, and other therapeutic uses. End users span the pharmaceutical industry, nutraceutical companies, cosmetics manufacturers, and research laboratories.

North America’s Leading Role in the Empty Capsules Market
North America is poised to hold the largest regional share in 2030, valued at $2.2 billion, growing from $1.4 billion in 2025 at a CAGR of 9%. This growth is supported by expanded pharmaceutical manufacturing capacity, strong demand for oral solid dosage forms, investment in sophisticated drug delivery systems, and increased production of prescription and nutraceutical products requiring quality encapsulation.

The USA as the Top National Market
By 2030, the United States is expected to be the largest single-country market, projected at $2.1 billion compared to $1.3 billion in 2025, reflecting a 10% CAGR. Growth here is driven by extensive R&D in drug formulations, increasing contract manufacturing of capsule-based dosage forms, demand for custom encapsulation in specialized therapies, and a growing nutraceutical sector aligned with evolving health trends.

Competitive Landscape in the Empty Capsules Market
The empty capsules market is shaped by global manufacturers and excipient suppliers specializing in both gelatin and non-gelatin technologies. These companies invest heavily in advanced capsule formulations, high-speed production capabilities, plant-based material development, and rigorous quality controls. Their competitive edge depends on adherence to regulatory standards, product consistency, ingredient compatibility, and reliable supply chains supporting clean-label and vegetarian preferences.

Market Share Distribution Among Top Players
The market is quite fragmented, with the top 10 players capturing only 6% of the total revenue in 2025. Key companies maintain their presence through comprehensive capsule portfolios, longstanding relationships with pharmaceutical and supplement manufacturers, global production networks, and ongoing innovations in both gelatin and plant-based capsules. Rising demand for clean-label, vegetarian, and customized dosing capsules will likely encourage further product innovations and strategic partnerships.

Leading Companies by Market Share in 2025
Lonza Group AG leads the pack, holding a 2% share, followed by ACG, Suheung Co. Ltd., and Natural Capsules Limited, each with about 1%. Other players with smaller shares include Sunil Healthcare Ltd., Shanxi Guangsheng Medicinal Capsule Co. Ltd., Lyfe Group (CapsCanada Corporation), Farmacapsulas SA de CV, Goerlich Pharma GmbH, and HealthCaps India Ltd., each under 0.5%.

Innovations Boosting Market Expansion
Automation in capsule manufacturing is a key growth driver, improving production efficiency, expanding supply capacities, and meeting rising demand. For instance, in December 2024, Lonza expanded its hard gelatin capsule production with new automated lines at facilities in Rewari, India, and Suzhou, China. These upgrades enhance annual output, provide a range of capsule sizes and colors, increase operational flexibility, and ensure supply stability across the Asia-Pacific region while adhering to high quality and sustainability standards.

Market Outlook and Growth Potential Through 2030
Both gelatin and non-gelatin capsule segments are expected to contribute more than $3 billion in new market value by 2030—the gelatin segment growing by $2 billion and the non-gelatin segment by $1 billion between 2025 and 2030. Growth will be driven by specialized oral dosage forms, advanced capsule materials, personalized medicines and nutraceuticals, and innovations in capsule filling that enhance flexibility, stability, and production efficiency.

Strategies Market Players Use to Stay Competitive
Key approaches include broadening the use of plant-based and clean-label capsules, engineering advanced formulations for improved dissolution and stability, adopting high-speed automated manufacturing to increase quality and output, delivering customized capsule solutions for niche drug and supplement needs, and integrating digital technologies to boost traceability and quality control.

Prominent Companies Operating in the Sector
Major participants in the empty capsules market include Lonza Group AG, ACG, Suheung Co. Ltd., Natural Capsules Limited, Sunil Healthcare Ltd., Shanxi Guangsheng Medicinal Capsule Co. Ltd., Lyfe Group (CapsCanada Corporation), Farmacapsulas SA de CV, Goerlich Pharma GmbH, HealthCaps India Ltd., along with others like Lefan Capsule Co. Ltd., Nectar Lifesciences Ltd., Wuhan Carma Technology Co. Ltd., Bright Pharma Caps Inc., Roxlor LLC, Comed Chemicals Limited, BioCaps Enterprise, Medi-Caps Ltd., Erawat Pharma Ltd., and Capsuline Inc.

Complete Value Chain From Raw Materials to Consumers
Raw material suppliers include companies such as Rousselot, GELITA AG, Nitta Gelatin Inc., Weishardt Group, PB Gelatins, Darling Ingredients Inc., Nippi Inc., Trobas Gelatine B.V., Ewald-Gelatine GmbH, Lapi Gelatine S.p.A., Roquette Frères, Ashland Inc., Shin-Etsu Chemical Co. Ltd., Dow Inc., BASF SE, DuPont de Nemours Inc., Ingredion Incorporated, Colorcon Inc., Sensient Technologies Corporation, and FMC Corporation.

Wholesalers and distributors cover firms like IMCD N.V., DKSH Holding Ltd., Univar Solutions Inc., Brenntag SE, Barentz International, Azelis Group, Caldic B.V., Biesterfeld AG, Connell Company, Aceto Corporation, Ravago Group, Nexeo Plastics, ChemPoint, Palmer Holland Inc., HELM AG, Redox Limited, Chemisphere Corporation, Stockmeier Group, Kreglinger Group, and Hawkins Inc.

End users comprise major pharmaceutical and nutraceutical companies including Pfizer Inc., Roche Holding AG, Novartis AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., AstraZeneca PLC, GSK plc, Eli Lilly and Company, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Amway Corporation, Herbalife Ltd., Haleon plc, and Nestlé Health Science.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 30,000+ reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.

Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.

Contact Us:
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: marketing@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X